A randomized study to evaluate effect of pioglitazone, exenatide and combined therapy with exenatide and pioglitazone on plasma metabolites in patients with type 2 diabetes mellitus.
Phase of Trial: Phase II
Latest Information Update: 30 Jul 2015
At a glance
- Drugs Exenatide (Primary) ; Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Therapeutic Use
- 30 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.